IMMUNE RESPONSE TO HELICOBACTER PYLORI ANTIGENS AND ITS IMPLICATIONS IN GASTRIC PATHOLOGY

Authors

  • Bazarova Gulnora Rustamovna Associate Professor at the “Alfraganus “ university’s medical faculty

DOI:

https://doi.org/10.37547/

Keywords:

Helicobacter pylori; gastric pathology; host immunity; immune evasion; molecular mimicry; immunoregulation

Abstract

Helicobacter pylori (H. pylori) is a Gram-negative bacterium with a marked affinity for gastric tissue and is globally recognized as a major cause of gastrointestinal disease. Chronic infection with H. pylori is implicated in a wide spectrum of disorders, including peptic ulcer disease, gastric adenocarcinoma, mucosa-associated lymphoid tissue (MALT) lymphoma, and several extra-gastric complications. The bacterium expresses multiple virulence factors—such as lipopolysaccharides (LPS), cytotoxin-associated gene A (CagA), vacuolating cytotoxin A (VacA), and a range of adhesins—that provoke a strong host immune response during the early stages of infection.

Downloads

Download data is not yet available.

References

1.Warren, J.R.; Marshall, B. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983, 1, 1273–1275. [Google Scholar] [PubMed]

2.Santacroce, L.; Topi, S.; Bottalico, L.; Charitos, I.A.; Jirillo, E. Current Knowledge about Gastric Microbiota with Special Emphasis on Helicobacter pylori-Related Gastric Conditions. Curr. Issues Mol. Biol. 2024, 46, 4991–5009. [Google Scholar] [CrossRef] [PubMed]

3.Suzuki, H.; Moayyedi, P. Helicobacter pylori infection in functional dyspepsia. Nat. Rev. Gastroenterol. Hepatol. 2013, 10, 168–174. [Google Scholar] [CrossRef]

4.Ansari, S.; Yamaoka, Y. Survival of Helicobacter pylori in gastric acidic territory. Helicobacter 2017, 22, e12386. [Google Scholar] [CrossRef] [PubMed]

5.Gu, H. Role of Flagella in the Pathogenesis of Helicobacter pylori. Curr. Microbiol. 2017, 74, 863–869. [Google Scholar] [CrossRef]

6.Backert, S.; Tegtmeyer, N.; Fischer, W. Composition, structure and function of the Helicobacter pylori cag pathogenicity island encoded type IV secretion system. Future Microbiol. 2015, 10, 955–965. [Google Scholar] [CrossRef] [PubMed]

7.Feedings, N.J.; Caston, R.R.; McClain, M.S.; Ohi, M.D.; Cover, T.L. An Overview of Helicobacter pylori VacA Toxin Biology. Toxins 2016, 8, 173. [Google Scholar] [CrossRef]

8.Kusters, J.G.; van Vliet, A.H.; Kuipers, E.J. Pathogenesis of Helicobacter pylori infection. Clin. Microbiol. Rev. 2006, 19, 449–490. [Google Scholar] [CrossRef]

9.Sukri, A.; Hanafiah, A.; Mohamad Zin, N.; Kosai, N.R. Epidemiology and role of Helicobacter pylori virulence factors in gastric cancer carcinogenesis. APMIS. 2020, 128, 150–161. [Google Scholar] [CrossRef] [PubMed]

10.Lembo, A.; Caradonna, L.; Magrone, T.; Mastronardi, M.L.; Caccavo, D.; Jirillo, E.; Amati, L. Helicobacter pylori organisms induce expression of activation and apoptotic surface markers on human lymphocytes and AGS cells: A cytofluorimetric evaluation. Immunopharmacol. Immunotoxicol. 2002, 24, 567–582. [Google Scholar] [CrossRef]

11.Hynes, S.O.; Ferris, J.A.; Szponar, B.; Wadström, T.; Fox, J.G.; O’Rourke, J.; Larsson, L.; Yaquian, E.; Ljungh, A.; Clyne, M.; et al. Comparative chemical and biological characterization of the lipopolysaccharides of gastric and enterohepatic helicobacters. Helicobacter 2004, 9, 313–323. [Google Scholar] [CrossRef] [PubMed]

12.Moran, A.P.; Aspinall, G.O. Unique structural and biological features of Helicobacter pylori lipopolysaccharides. Prog. Clin. Biol. Res. 1998, 397, 37–49. [Google Scholar] [PubMed]

13.Miller, S.I.; Ernst, R.K.; Bader, M.W. LPS, TLR4 and infectious disease diversity. Nat. Rev. Microbiol. 2005, 3, 36–46. [Google Scholar] [CrossRef]

14.Smith MFJr Mitchell, A.; Li, G.; Ding, S.; Fitzmaurice, A.M.; Ryan, K.; Crowe, S.; Goldberg, J.B. Toll-like receptor (TLR) 2 and TLR5, but not TLR4, are required for Helicobacter pylori-induced NF-kappa B activation and chemokine expression by epithelial cells. J. Biol. Chem. 2003, 278, 32552–32560. [Google Scholar] [CrossRef]

15.Russo, F.; Jirillo, E.; Clemente, C.; Messa, C.; Chiloiro, M.; Riezzo, G.; Amati, L.; Caradonna, L.; Di Leo, A. Circulating cytokines and gastrin levels in asymptomatic subjects infected by Helicobacter pylori (H. pylori). Immunopharmacol. Immunotoxicol. 2001, 23, 13–24. [Google Scholar] [CrossRef]

16.Bagheri, N.; Azadegan-Dehkordi, F.; Rahimian, G.; Rafieian-Kopaei, M.; Shirzad, H. Role of Regulatory T-cells in Different Clinical Expressions of Helicobacter pylori Infection. Arch. Med. Res. 2016, 47, 245–254. [Google Scholar] [CrossRef] [PubMed]

17.Russo, F.; Messa, C.; Amati, L.; Caradonna, L.; Leoci, C.; Di Matteo, G.; Jirillo, E.; Di Leo, A. The influence of Helicobacter pylori eradication on the gastric mucosal content of epidermal growth factor, transforming growth factor-alpha, and their common receptor. Scand. J. Gastroenterol. 1998, 33, 271–275. [Google Scholar] [CrossRef]

18.Topi, S.; Santacroce, L.; Bottalico, L.; Ballini, A.; Inchingolo, A.D.; Dipalma, G.; Charitos, I.A.; Inchingolo, F. Gastric Cancer in History: A Perspective Interdisciplinary Study. Cancers 2020, 12, 264. [Google Scholar] [CrossRef]

19.Muotiala, A.; Helander, I.M.; Pyhälä, L.; Kosunen, T.U.; Moran, A.P. Low biological activity of Helicobacter pylori lipopolysaccharide. Infect. Immun. 1992, 60, 1714–1716. [Google Scholar] [CrossRef]

20.Moran, A.P.; Lindner, B.; Walsh, E.J. Structural characterization of the lipid A component of Helicobacter pylori rough- and smooth-form lipopolysaccharides. J. Bacteriol. 1997, 179, 6453–6463. [Google Scholar] [CrossRef]

21.Stead, C.M.; Beasley, A.; Cotter, R.J.; Trent, M.S. Deciphering the unusual acylation pattern of Helicobacter pylori lipid A. J. Bacteriol. 2008, 190, 7012–7021. [Google Scholar] [CrossRef] [PubMed]

22.Freudenberg, M.A.; Galanos, C. Bacterial lipopolysaccharides: Structure, metabolism and mechanisms of action. Int. Rev. Immunol. 1990, 6, 207–221. [Google Scholar] [CrossRef]

23.Mattsby-Baltzer, I.; Mielniczuk, Z.; Larsson, L.; Lindgren, K.; Goodwin, S. Lipid A in Helicobacter pylori. Infect. Immun. 1992, 60, 4383–4387. [Google Scholar] [CrossRef] [PubMed]

24.Appelmelk, B.J.; Negrini, R.; Moran, A.P.; Kuipers, E.J. Molecular mimicry between Helicobacter pylori and the host. Trends Microbiol. 1997, 5, 70–73. [Google Scholar] [CrossRef]

Downloads

Published

2025-10-21

How to Cite

IMMUNE RESPONSE TO HELICOBACTER PYLORI ANTIGENS AND ITS IMPLICATIONS IN GASTRIC PATHOLOGY. (2025). International Bulletin of Medical Sciences and Clinical Research, 5(10), 80-93. https://doi.org/10.37547/

Similar Articles

1-10 of 106

You may also start an advanced similarity search for this article.